PMC:7377212 / 3369-3598 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T64","span":{"begin":33,"end":37},"obj":"Disease"},{"id":"T65","span":{"begin":49,"end":71},"obj":"Disease"},{"id":"T66","span":{"begin":58,"end":71},"obj":"Disease"},{"id":"T67","span":{"begin":169,"end":177},"obj":"Disease"},{"id":"T68","span":{"begin":224,"end":228},"obj":"Disease"}],"attributes":[{"id":"A64","pred":"mondo_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A65","pred":"mondo_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A66","pred":"mondo_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A67","pred":"mondo_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A68","pred":"mondo_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"}],"text":"e reports of patients developing SARS-associated invasive aspergillosis after corticosteroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T24","span":{"begin":121,"end":124},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"e reports of patients developing SARS-associated invasive aspergillosis after corticosteroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":78,"end":92},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"e reports of patients developing SARS-associated invasive aspergillosis after corticosteroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA."}

{"project":"MyTest","denotations":[{"id":"32703771-12890854-29390906","span":{"begin":98,"end":99},"obj":"12890854"},{"id":"32703771-32171076-29390907","span":{"begin":179,"end":180},"obj":"32171076"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"e reports of patients developing SARS-associated invasive aspergillosis after corticosteroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA."}

{"project":"LitCovid-sentences","denotations":[{"id":"T21","span":{"begin":102,"end":229},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"e reports of patients developing SARS-associated invasive aspergillosis after corticosteroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA."}

{"project":"2_test","denotations":[{"id":"32703771-12890854-29390906","span":{"begin":98,"end":99},"obj":"12890854"},{"id":"32703771-32171076-29390907","span":{"begin":179,"end":180},"obj":"32171076"}],"text":"e reports of patients developing SARS-associated invasive aspergillosis after corticosteroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA."}